2.75
Mdxhealth Sa Borsa (MDXH) Ultime notizie
Using RSI to spot recovery in MDxHealth SABond Market & Weekly Return Optimization Alerts - Newser
MDxHealth (MDXH) Expected to Announce Quarterly Earnings on Wednesday - Defense World
What MACD and RSI say about MDxHealth SAJuly 2025 Drop Watch & Capital Efficient Trade Techniques - Newser
Automated trading signals detected on MDxHealth SAFree Daily Volume Spike Trading Signals - Newser
MDxHealth SA stock trend forecastDividend Hike & Weekly Consistent Profit Watchlists - Newser
Why MDxHealth SA stock attracts strong analyst attentionMarket Activity Recap & Weekly Sector Rotation Insights - Newser
What makes MDxHealth SA stock price move sharplyMulti-Timeframe Confluence Picks - thegnnews.com
Will MDxHealth SA stock recover after recent dropPredictable Entry Strategy With Technical Backing - Newser
News impact scoring models applied to MDxHealth SADaily Market Movers Screener with Filters - Newser
MDxHealth SA stock prediction for this week3-Day Market Movement Forecast Analysis - Newser
Earnings visualization tools for MDxHealth SAConsistent Gain Plan with AI Support - Newser
Is MDxHealth SA forming a bottoming baseStock Performance Summary Over One Year - Newser
Financial Analysis: MDxHealth (NASDAQ:MDXH) and Standard BioTools (NASDAQ:LAB) - Defense World
Order flow analysis tools used on MDxHealth SAReal Trader Watchlist with Entry Targets - Newser
Bio-Techne takes a hit on Exodx sale to Mdxhealth - BioWorld MedTech
MDxHealth SA (MDXH) Reports Q2 Loss, Tops Revenue Estimates - MSN
MDxHealth SA (MDXH) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance
MDxHealth ADR earnings missed by $0.03, revenue topped estimates - Investing.com South Africa
MDxHealth Announces Q2 Results and Strategic Acquisition of Exosome Diagnostics - TipRanks
Bio-Techne announces Exosome Diagnostics divestiture - MSN
Bio-techne to sell exosome diagnostics business to mdxhealth By Investing.com - Investing.com Australia
Bio-techne to sell exosome diagnostics business to mdxhealth - Investing.com
Bio-Techne Sells Prostate Cancer Test Business to Strengthen Core Operations: Strategic Shift Revealed - Stock Titan
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne - The Manila Times
MDxHealth Hits Profitability Milestone and Expands Diagnostic Portfolio with Strategic $15M ExoDx Acquisition - Stock Titan
MACD Cross Could Confirm Trend in MDxHealth SATarget Return Focused Trade Insights Shared - metal.it
Is MDxHealth SA a growth stock or a value stockOutstanding capital growth - Jammu Links News
When is MDxHealth SA stock expected to show significant growthUnlock expert trading strategies for growth - Jammu Links News
What are the latest earnings results for MDxHealth SACapitalize on momentum-driven investment opportunities - Jammu Links News
Is MDxHealth SA stock overvalued or undervaluedUnlock exclusive stock market insights - Jammu Links News
Why is MDxHealth SA stock attracting strong analyst attentionMaximize returns with expert trading insights - Jammu Links News
How does MDxHealth SA compare to its industry peersExceptional stock performance - Jammu Links News
How many analysts rate MDxHealth SA as a “Buy”Unlock powerful market trend analysis - Jammu Links News
What catalysts could drive MDxHealth SA stock higher in 2025Free Stock Market Trend Analysis - Jammu Links News
What drives MDxHealth SA stock priceSuperior profit margins - Jammu Links News
Is it the right time to buy MDxHealth SA stockUnlock exclusive trading strategies - Jammu Links News
What are the technical indicators suggesting about MDxHealth SACapitalize on market trends with confidence - Jammu Links News
What are analysts’ price targets for MDxHealth SA in the next 12 monthsFind the best stocks for sustainable growth - Jammu Links News
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):